Skip to main content
Trusted advisor to healthcare practitioners · Est. 2016

Practice Operations · For practice managers

CLIA Compliance Requirements for In-Office PRP Preparation

Published November 21, 2026

CLIA Jurisdiction Trigger
Diagnostic vs. Therapeutic Intent

CLIA applies only when human specimens are analyzed to generate diagnostic or health-assessment data, not during closed-loop autologous tissue processing.

Primary Device Regulation
FDA 510(k) Clearance

In-office PRP preparation systems are regulated as Class II medical devices under FDA CDRH rather than clinical laboratory analyzers.

Workplace Safety Standard
OSHA 29 CFR 1910.1030

All point-of-care blood processing requires adherence to federal Bloodborne Pathogens standards, including aerosol containment during centrifugation.

Point-of-care autologous blood processing falls outside federal CLIA oversight because centrifuging platelet-rich plasma constitutes biological preparation for immediate therapeutic re-implantation rather than an in vitro diagnostic assay. While practices do not need a CLIA certificate of waiver simply to spin whole blood, compliance scrutiny instead centers on utilizing FDA 510(k)-cleared collection systems and enforcing closed-system sterility under OSHA bloodborne pathogen standards. Defining this operational boundary between procedural manipulation and regulated clinical laboratory testing is essential for protecting your practice against compliance missteps during state board and accreditation audits.

Understanding the Regulatory Boundary: CLIA vs. Point-of-Care Processing

For practice managers and administrators setting up a regenerative medicine service line, regulatory terminology often overlaps. Because PRP preparation requires venipuncture, anticoagulants, and a centrifuge—equipment found in almost every diagnostic laboratory—administrators frequently ask about CLIA compliance requirements for in office PRP preparation centrifuge operations.

The Centers for Medicare & Medicaid Services (CMS) regulates all laboratory testing performed on humans in the United States through CLIA. The operative definition under CLIA is whether a facility examines human specimens for the purpose of providing information for the diagnosis, prevention, or treatment of any disease, or the assessment of the health of human beings.

When a staff member draws a patient's blood, places it in an FDA-cleared PRP isolation tube, spins it in a centrifuge, and extracts the platelet buffy coat or plasma layer for immediate re-injection into the same patient, no diagnostic information is being generated. The centrifuge is acting as a point-of-care processing tool, not an analytical instrument. Consequently, the act of centrifuging blood to prepare autologous PRP falls outside CLIA jurisdiction.

When CLIA Does Apply to a PRP Workflow

While the centrifuge itself does not trigger CLIA, adjacent quality-control practices inside a regenerative clinic can cross the threshold into regulated laboratory testing:

  • Baseline and Post-Spin Hematology Analysis: Some orthopedics and sports medicine clinics measure the patient's baseline whole-blood platelet count and the final PRP platelet concentration using a benchtop hematology analyzer to document the concentration factor in the patient's chart. Because this analyzer generates quantitative patient data used to assess treatment quality or adjust volume, operating that analyzer requires the appropriate CLIA certificate (typically a Certificate of Compliance or Certificate of Accreditation for moderate-complexity testing).
  • Pre-Procedure Diagnostic Screening: If the clinic runs point-of-care diagnostic tests prior to the procedure—such as rapid screening panels, hemoglobin checks, or urinalysis—those specific tests must operate under an active CLIA Certificate of Waiver or higher, depending on the test complexity.

The Actual Regulatory Framework for In-Office PRP

If CLIA does not govern the centrifuge, what regulatory bodies oversee in-office autologous biologics? Practice administrators must align their standard operating procedures (SOPs) with three primary frameworks.

1. FDA 21 CFR Part 1271 and 510(k) Device Clearance

Under FDA regulations regarding Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps), autologous blood components like PRP are exempt from stringent biologic licensing requirements provided they meet specific exemptions—chiefly the "same surgical procedure" exception.

However, the devices used to manufacture PRP at the point of care are regulated by the FDA Center for Devices and Radiological Health (CDRH). To maintain compliance, practices should use centrifuges and separation kits that hold FDA 510(k) clearance specifically for the preparation of autologous platelet-rich plasma. Using standard laboratory blood-draw tubes (such as yellow-top ACD tubes or lavender-top EDTA tubes intended solely for diagnostic lab transport) to prepare injectable PRP is considered an off-label use of an unapproved collection device and introduces substantial regulatory and liability exposure. Sourcing purpose-built, cleared kits through an established biologics and devices distributor protects the practice during audits.

2. OSHA Bloodborne Pathogens Standard (29 CFR 1910.1030)

Because PRP processing involves handling human blood, transferring fluids between syringes, and operating high-speed rotary equipment, OSHA compliance is mandatory. Centrifugation carries the specific risk of aerosolization if a tube cracks or a cap leaks under high relative centrifugal force (RCF).

Administrators must ensure the facility maintains:

  • An updated Exposure Control Plan reviewed annually.
  • Engineering controls, including centrifuges with sealed safety buckets or rotors that contain aerosols if a tube breaks.
  • Proper personal protective equipment (PPE) and sharps disposal containers stocked via compliant medical supplies.
  • Documented Hepatitis B vaccination records (or signed declinations) and post-exposure protocols for all staff handling blood products.

3. State Medical Board Scope of Practice

State regulations dictate who may perform the venipuncture, who may operate the processing equipment, and who may perform the final re-injection. While medical assistants or phlebotomists are often permitted to draw the blood and run the centrifuge under physician supervision, the injection of the biologic into a joint, tendon sheath, or dermal plane is strictly limited to licensed clinicians (MD, DO, NP, PA, or RN depending on the anatomical site and state law).

Compliance and Operational Checklist for PRP Centrifugation

Even without a CLIA mandate on the centrifuge, treating your PRP preparation area with laboratory-grade discipline reduces contamination risk, ensures consistent platelet recovery, and satisfies malpractice carriers. Implement the following operational checklist:

  • Device Verification: Retain the FDA 510(k) clearance documentation on file for both the centrifuge and the disposable PRP preparation kits.
  • Closed-System Preference: Utilize closed-system PRP kits whenever possible to minimize exposure of the blood specimen to ambient room air during transfers.
  • Tachometer and Timer Calibration: Schedule annual biomedical inspection and calibration of the centrifuge to verify that the displayed RPM/RCF and spin times match actual mechanical output.
  • Mechanical Balancing Logs: Train staff to always balance the rotor using a counterweight tube filled with a liquid of equivalent specific gravity (such as saline) if spinning an odd number of patient tubes.
  • Decontamination Protocols: Log daily disinfection of the centrifuge chamber, rotor, and buckets using an EPA-registered tuberculocidal disinfectant that is safe for the rotor's metallurgy (avoiding harsh bleach concentrations on aluminum rotors unless specified by the manufacturer).
  • Lot Number Traceability: Record the lot number and expiration date of the PRP collection kit and anticoagulant in the patient's electronic health record (EHR) for every procedure.
  • Aseptic Workflow Zoning: Clearly separate the "dirty" blood collection/centrifugation zone from the "clean" sterile tray preparation zone.

Clinical Perspective: Why Compliance Directly Impacts Patient Outcomes

For the physicians, orthopedic specialists, and aesthetic providers performing the injections, operational compliance is not merely administrative paperwork—it directly dictates the biological quality of the graft. Specialists across orthopedics and aesthetics rely on predictable platelet concentrations and specific leukocyte profiles (leukocyte-rich vs. leukocyte-poor PRP) to achieve desired tissue responses.

When a practice cuts corners by using laboratory diagnostic tubes instead of FDA-cleared PRP kits, two clinical problems arise. First, diagnostic tubes are not sterilized or pyrogen-tested for human re-injection; introducing endotoxins or tube-wall silicones into an intra-articular space or facial tissue can trigger sterile inflammatory reactions. Second, uncalibrated centrifuges or improper tube geometry alters the relative centrifugal force (RCF) at the buffy coat interface. If the spin is too hard, platelets undergo premature degranulation or become trapped in the red blood cell pack; if the spin is too light, platelets remain suspended in the platelet-poor plasma layer and are discarded. Strict adherence to device manufacturer protocols and annual centrifuge calibration ensures the clinician injects a viable, predictable biologic product every time.

What This Means for Your Practice

If you are launching or auditing an in-office PRP program, your immediate administrative priorities should focus on device clearance and infection control rather than applying for a CLIA license—unless you plan to run in-house hematology counts.

  1. Audit Your Consumables: Check your current inventory of collection tubes. If your staff is drawing blood into standard laboratory vacutainers for re-injection, transition immediately to an FDA 510(k)-cleared PRP system.
  2. Verify Your Ancillary Testing: Determine whether your providers want to run quantitative platelet counts in-house. If not, no CLIA action is required for the PRP workflow. If they do, apply for the appropriate CLIA certificate before purchasing a hematology analyzer.
  3. Standardize Maintenance Logs: Create a binder (physical or digital) containing the centrifuge manual, FDA 510(k) summary, daily cleaning logs, and annual biomedical calibration stickers.
  4. Review Staff Credentials: Confirm that your delegation of blood draws, processing, and injections aligns with your state medical board's current supervision requirements.

If your practice is evaluating compliant PRP systems, biologics, or point-of-care devices, the team at Dallas Regenerative Solutions can help you structure a clean, defensible workflow. Reach out through our contact page to schedule an operational consultation.

Frequently asked questions

Do you need a CLIA waiver to spin blood for PRP in a medical office?
No, a CLIA Certificate of Waiver is not required simply to centrifuge blood for autologous PRP preparation. CLIA regulates diagnostic testing that provides information to assess health or diagnose disease, whereas preparing PRP for immediate re-injection is classified as a point-of-care therapeutic procedure.
When does a regenerative medicine clinic need a CLIA certificate?
A clinic needs a CLIA certificate if it uses a benchtop hematology analyzer to measure baseline whole-blood cell counts or final PRP platelet concentrations to guide patient care. It also needs a CLIA certificate if it performs any pre-procedure point-of-care diagnostic tests, such as rapid infectious disease screenings or urinalysis.
Can a practice use standard laboratory vacutainer tubes to make PRP?
No, standard laboratory diagnostic tubes (such as lavender-top EDTA or yellow-top ACD vacutainers) are cleared only for in vitro diagnostic testing, not for preparing products to be re-injected into humans. Practices should use collection kits and centrifuges that hold specific FDA 510(k) clearance for autologous PRP preparation.
How often should an in-office PRP centrifuge be calibrated?
While CLIA does not mandate the schedule for non-diagnostic centrifuges, medical device best practices and accrediting bodies generally expect annual biomedical inspection and calibration. Regular verification ensures the tachometer and timer remain accurate, which is essential for consistent platelet separation.
What OSHA rules apply to in-office PRP preparation?
Practices must comply with the OSHA Bloodborne Pathogens Standard (29 CFR 1910.1030). This requires a written Exposure Control Plan, staff training, Hepatitis B vaccination tracking, appropriate PPE, sharps disposal, and using centrifuge rotors or safety cups designed to contain biohazardous aerosols in the event of a tube break.

Bring regenerative medicine into your practice.

Talk with our team about biologics, devices, or an AI-powered peptide protocol tailored to your patients.

Request Consultation →